Spironolactone Against Anthracycline-induced Cardiomyopathy
NCT02053974
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Anthracycline Induced Cardiotoxicity
Interventions
DRUG:
Spironolactone
OTHER:
Placebo
Sponsor
TC Erciyes University